142 related articles for article (PubMed ID: 38086927)
1. Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder.
Beversdorf DQ; Ferguson B; Hunter S; Hirst K; Lolli B; Bellesheim KR; Barton AU; Muckerman J; Takahashi N; Selders K; Holem R; Sohl K; Dyke P; Stichter J; Mazurek M; Kanne S
Psychopharmacology (Berl); 2024 Jan; 241(1):19-32. PubMed ID: 38086927
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers.
Zamzow RM; Ferguson BJ; Ragsdale AS; Lewis ML; Beversdorf DQ
J Clin Exp Neuropsychol; 2017 Aug; 39(6):596-606. PubMed ID: 27841098
[TBL] [Abstract][Full Text] [Related]
3. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
Zamzow RM; Ferguson BJ; Stichter JP; Porges EC; Ragsdale AS; Lewis ML; Beversdorf DQ
Psychopharmacology (Berl); 2016 Apr; 233(7):1171-8. PubMed ID: 26762378
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Feasibility Study Assessing the Combined Effects of Early Behavioral Intervention and Propranolol on Autism Spectrum Disorder (ASD).
Hirst K; Zamzow RM; Stichter JP; Beversdorf DQ
Children (Basel); 2023 Sep; 10(10):. PubMed ID: 37892301
[TBL] [Abstract][Full Text] [Related]
5. Using the Clinical Global Impression scale to assess social communication change in minimally verbal children with autism spectrum disorder.
Toolan C; Holbrook A; Schlink A; Shire S; Brady N; Kasari C
Autism Res; 2022 Feb; 15(2):284-295. PubMed ID: 34800004
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder.
Hegarty JP; Ferguson BJ; Zamzow RM; Rohowetz LJ; Johnson JD; Christ SE; Beversdorf DQ
Brain Imaging Behav; 2017 Oct; 11(5):1278-1289. PubMed ID: 27714553
[TBL] [Abstract][Full Text] [Related]
8. Effect of propranolol on facial scanning in autism spectrum disorder: a preliminary investigation.
Zamzow RM; Christ SE; Saklayen SS; Moffitt AJ; Bodner KE; Higgins KF; Beversdorf DQ
J Clin Exp Neuropsychol; 2014; 36(4):431-45. PubMed ID: 24730708
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial.
Hollander E; Jacob S; Jou R; McNamara N; Sikich L; Tobe R; Smith J; Sanders K; Squassante L; Murtagh L; Gleissl T; Wandel C; Veenstra-VanderWeele J
JAMA Psychiatry; 2022 Aug; 79(8):760-769. PubMed ID: 35793101
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder.
McDougle CJ; Thom RP; Ravichandran CT; Palumbo ML; Politte LC; Mullett JE; Keary CJ; Erickson CA; Stigler KA; Mathieu-Frasier L; Posey DJ
Neuropsychopharmacology; 2022 May; 47(6):1263-1270. PubMed ID: 35241779
[TBL] [Abstract][Full Text] [Related]
12. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
[TBL] [Abstract][Full Text] [Related]
13. Communication interventions for autism spectrum disorder in minimally verbal children.
Brignell A; Chenausky KV; Song H; Zhu J; Suo C; Morgan AT
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012324. PubMed ID: 30395694
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
Aye SZ; Ni H; Sein HH; Mon ST; Zheng Q; Wong YKY
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013457. PubMed ID: 33583058
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
Zimmerman AW; Singh K; Connors SL; Liu H; Panjwani AA; Lee LC; Diggins E; Foley A; Melnyk S; Singh IN; James SJ; Frye RE; Fahey JW
Mol Autism; 2021 May; 12(1):38. PubMed ID: 34034808
[TBL] [Abstract][Full Text] [Related]
16. A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1.
Parellada M; San José Cáceres A; Palmer M; Delorme R; Jones EJH; Parr JR; Anagnostou E; Murphy DGM; Loth E; Wang PP; Charman T; Strydom A; Arango C
Front Psychiatry; 2021; 12():701729. PubMed ID: 34504446
[No Abstract] [Full Text] [Related]
17. Memantine for autism spectrum disorder.
Brignell A; Marraffa C; Williams K; May T
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013845. PubMed ID: 36006807
[TBL] [Abstract][Full Text] [Related]
18. Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders.
Sagar-Ouriaghli I; Lievesley K; Santosh PJ
J Psychopharmacol; 2018 Jun; 32(6):641-653. PubMed ID: 29484909
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid treatment for autism: a proof-of-concept randomized trial.
Aran A; Harel M; Cassuto H; Polyansky L; Schnapp A; Wattad N; Shmueli D; Golan D; Castellanos FX
Mol Autism; 2021 Feb; 12(1):6. PubMed ID: 33536055
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder: A Randomized Clinical Trial.
Wood JJ; Kendall PC; Wood KS; Kerns CM; Seltzer M; Small BJ; Lewin AB; Storch EA
JAMA Psychiatry; 2020 May; 77(5):474-483. PubMed ID: 31755906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
